Anticoagulants
42
2
2
21
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.8%
2 terminated out of 42 trials
91.3%
+4.8% vs benchmark
24%
10 trials in Phase 3/4
29%
6 of 21 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 21 completed trials
Clinical Trials (42)
Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients With Atrial Fibrillation
Anticoagulation Profile in Pregnant Women Treated With Three Times a Day of Low Molecular Weight Heparin (LMWH)
MIDAS Cluster Randomized Controlled Trial of Implementation Strategies to Optimize Use of Medications in VA Clinical Settings
Shared Decision for Drug Interactions in Oral Anticoagulation
Optimal Duration of Anticoagulation Therapy for Low-risk Pulmonary Embolism Patients With Cancer
Dialysis Performance of the FX CorAL Membrane
A Study of Direct Oral Anticoagulants in Patients with Painful Venous Malformations with Localized Intravascular Coagulation
Variability in Micro-CT Imaging Results to Quantify Dialyzer Clotting
Efficacy, Safety and Pharmacokinetics of Tinzaparin During Slow Low Efficient Daily Dialysis in Intensive Care Patients
Application of "I-Anticoagulation"in Patients With Atrial Fibrillation
Self-care and Self-efficacy Scale in Oral Anticoagulation Therapy
Association of Obesity and Cardiovascular Outcomes in Atrial Fibrillation
Effectiveness And Safety Of Oral Anticoagulants Among Obese Patients With Non-Valvular A-Fib In VA Patients With Medicare
Apixaban for Extended Anticoagulation (APIDULCIS)
Epidemiological Description of Health Determinants in Italian Anticoagulated Population
Study Comparing Bivalirudin Versus Heparin in Neonatal and Pediatric ECMO
Coordination of Oral Anticoagulant Care at Hospital Discharge
AntiPlatelet theraPy stratEgy followiNg Left Atrial appenDAGe closurE
Pharmacists' Intervention in Patients Using Novel Oral Anticoagulants:A Study on Behavioral Patterns
Pharmacoepidemiology Treatment of Symptomatic Pulmonary Embolism in Hospitalized Patients Aged 75 Years or More: PEAGE